New research provides credible evidence that injectable treatments using a type of HDL or good cholesterol can delay heart diseases in patients with arterial blockage. The results of this research were published in the Journal of the American Medical Association on Wednesday. According to the journal, in a small trial consisting of forty-seven patients, volunteers who received chemical cholesterol injections weekly observed significant changes within just six weeks. A cardiologist who led the research stated that the results obtained created a new perspective on the treatment of arteriosclerosis. Further and more extensive studies are still needed to confirm the results of the initial trial and to assess its safety. Therefore, it will take several years before this type of treatment is available for public use.
New Treatment for Heart Diseases - 2003-11-05
New research suggests that injectable HDL treatments can delay heart diseases in patients with arterial blockages. A small trial showed significant improvements in just six weeks. This development could change the approach to treating arteriosclerosis, but more studies are needed before public availability.
👥 Key Players
📰 What Happened
New research indicates that injectable treatments using HDL cholesterol can delay heart disease in patients with arterial blockages. A small trial showed significant improvements in just six weeks, suggesting a potential shift in treating arteriosclerosis.
- The trial involved 47 patients who received weekly cholesterol injections.
- Further extensive studies are needed to confirm the safety and efficacy of this treatment.
💡 Why It Matters
📚 Background
Heart disease is a leading cause of mortality worldwide, and innovative treatments are crucial for improving health outcomes. HDL cholesterol is often referred to as 'good' cholesterol, which helps remove other forms of cholesterol from the bloodstream.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%